Dysregulated homeobox genes are promising biomarkers for the diagnosis, prognosis, and therapy of bladder cancer, as they are directly associated with bladder tumorigenesis and clinically relevant bladder cancer outcomes. The gene discussed is LBX1; the disease is carcinoma.